These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 11726926)

  • 1. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease.
    Backman SA; Stambolic V; Suzuki A; Haight J; Elia A; Pretorius J; Tsao MS; Shannon P; Bolon B; Ivy GO; Mak TW
    Nat Genet; 2001 Dec; 29(4):396-403. PubMed ID: 11726926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease.
    Kwon CH; Zhu X; Zhang J; Knoop LL; Tharp R; Smeyne RJ; Eberhart CG; Burger PC; Baker SJ
    Nat Genet; 2001 Dec; 29(4):404-11. PubMed ID: 11726927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo.
    Kwon CH; Zhu X; Zhang J; Baker SJ
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12923-8. PubMed ID: 14534328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S6k1 is not required for Pten-deficient neuronal hypertrophy.
    Chalhoub N; Kozma SC; Baker SJ
    Brain Res; 2006 Jul; 1100(1):32-41. PubMed ID: 16777079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN function in mammalian cell size regulation.
    Backman S; Stambolic V; Mak T
    Curr Opin Neurobiol; 2002 Oct; 12(5):516-22. PubMed ID: 12367630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults.
    Zhou XP; Marsh DJ; Morrison CD; Chaudhury AR; Maxwell M; Reifenberger G; Eng C
    Am J Hum Genet; 2003 Nov; 73(5):1191-8. PubMed ID: 14566704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A heterozygous frameshift mutation of the PTEN/MMAC1 gene in a patient with Lhermitte-Duclos disease - only the mutated allele was expressed in the cerebellar tumor.
    Iida S; Tanaka Y; Fujii H; Hayashi S; Kimura M; Nagareda T; Moriwaki K
    Int J Mol Med; 1998 Jun; 1(6):925-9. PubMed ID: 9852626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
    Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological functions of Pten in mouse tissues.
    Kishimoto H; Hamada K; Saunders M; Backman S; Sasaki T; Nakano T; Mak TW; Suzuki A
    Cell Struct Funct; 2003 Feb; 28(1):11-21. PubMed ID: 12655146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN regulation of neural development and CNS stem cells.
    Li L; Liu F; Ross AH
    J Cell Biochem; 2003 Jan; 88(1):24-8. PubMed ID: 12461771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway.
    Abel TW; Baker SJ; Fraser MM; Tihan T; Nelson JS; Yachnis AT; Bouffard JP; Mena H; Burger PC; Eberhart CG
    J Neuropathol Exp Neurol; 2005 Apr; 64(4):341-9. PubMed ID: 15835270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice.
    Suzuki A; de la Pompa JL; Stambolic V; Elia AJ; Sasaki T; del Barco Barrantes I; Ho A; Wakeham A; Itie A; Khoo W; Fukumoto M; Mak TW
    Curr Biol; 1998 Oct; 8(21):1169-78. PubMed ID: 9799734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN: life as a tumor suppressor.
    Simpson L; Parsons R
    Exp Cell Res; 2001 Mar; 264(1):29-41. PubMed ID: 11237521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.
    Liaw D; Marsh DJ; Li J; Dahia PL; Wang SI; Zheng Z; Bose S; Call KM; Tsou HC; Peacocke M; Eng C; Parsons R
    Nat Genet; 1997 May; 16(1):64-7. PubMed ID: 9140396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases.
    Liliental J; Moon SY; Lesche R; Mamillapalli R; Li D; Zheng Y; Sun H; Wu H
    Curr Biol; 2000 Apr; 10(7):401-4. PubMed ID: 10753747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
    Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
    Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pten is essential for embryonic development and tumour suppression.
    Di Cristofano A; Pesce B; Cordon-Cardo C; Pandolfi PP
    Nat Genet; 1998 Aug; 19(4):348-55. PubMed ID: 9697695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cowden disease and the PTEN gene: a successfully clinical and biological combined approach].
    Longy M
    Bull Cancer; 2001 Dec; 88(12):1153-8. PubMed ID: 11792608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lhermitte-Duclos disease as a component of Cowden's syndrome. Case report and review of the literature.
    Koch R; Scholz M; Nelen MR; Schwechheimer K; Epplen JT; Harders AG
    J Neurosurg; 1999 Apr; 90(4):776-9. PubMed ID: 10193626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.